Skip to main content
. 2012 Mar 21;12:11. doi: 10.1186/1471-2318-12-11

Figure 2.

Figure 2

Achievement of sUA <6.0 mg/dL--All Subjects (Primary Endpoint) and by Renal Function. Data regarding the percentage of subjects with normal renal function with sUA <6.0 mg/dL is not presented due to the low number of subjects in this group (N = 6). ap = 0.029 vs allopurinol; bp ≤ 0.001 vs febuxostat 40 mg; cp < 0.001 vs allopurinol; dp = 0.004 vs allopurinol.